Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2003
06/19/2003WO2002020801A3 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
06/19/2003WO2002004664A3 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells
06/19/2003WO2002004514A3 Compositions and methods for the therapy and diagnosis of lung cancer
06/19/2003WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels
06/19/2003WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies
06/19/2003US20030114658 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
06/19/2003US20030114643 Regulation of human serotonin-like g protein-coupled receptor
06/19/2003US20030114410 Angiogenesis inhibition by administering into the tissue a molecule ,e.g., novel platelet factor 4 binding protein, to deactivate a lysyl oxidase; antimetastasis, -carcinogenic and -tumor agents; suppression of fibrosis
06/19/2003US20030114406 Dihydrazide derivatized hyaluronic acid crosslinked to a nucleic acid to transfect a cell, e.g. heart cell, to encoding a protein, e.g., endotheilial growth factor, to increase angiogenesis; antiischemic agents
06/19/2003US20030114405 Administering a conjugate of a non-immunogenic valency platform molecule, e.g., biodegradable polymer or protein, and at least two double stranded DNA epitopes, e,g., DNA molecules, which bind to anti-DNA antibodies from the patient
06/19/2003US20030114401 Antisense modulation of Ship-1 expression
06/19/2003US20030114399 Human and mouse choline transporter cDNA
06/19/2003US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma
06/19/2003US20030114383 Calcitonin-like sequence expressed by gonadotropes of the anterior pituitary
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114379 Encoded protein for treating leukemia, leukocytes, and bone marrow stem cell colony formation
06/19/2003US20030114378 Mouse pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
06/19/2003US20030113920 Transducting, dividing cells; gene expression; gene therapy
06/19/2003US20030113909 G protein coupled receptor protein, production and use thereof
06/19/2003US20030113898 Methods for producing high titre vectors and compositions used in such methods
06/19/2003US20030113894 Therapy for kidney diseases; cardiovascular disorders
06/19/2003US20030113869 Human FGF gene and gene expression products
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113796 Detecting modulators of cytokine activity; antiinflammatory agents; autoimmune diseases
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113720 cDNAs expressed in adipocyte differentiation
06/19/2003US20030113348 Non-laboratory strain used in the manufacture of a medicament for the oncolytic treatment of cancer; anticancer agents
06/19/2003US20030113347 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
06/19/2003US20030113337 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
06/19/2003US20030113329 An isolated polynucleotide encoding the enzyme polypeptide, genetic engineering, diagnostic kit, drug screening, antibodies; theraptic treatment of cancer, anemia, and end-stage renal disease
06/19/2003US20030113323 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity
06/19/2003US20030113305 Compositions and methods for treating diabetes
06/19/2003US20030113303 Delivering a translocation stimulator to a target zone of the tissue, introducing human embryonic stem cells to the mammal for homing the human to the target zone of the tissue for effecting myogenesis at the target zone
06/19/2003US20030113296 A tissue-specific transcriptional regulatory sequence(promoter or enhancer) operably linked to the coding region of a gene that is essential of replication of the vector (DNA tumor viral vector)
06/19/2003US20030113295 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
06/19/2003US20030113294 Introducing into the mammalian cell an agent containing DNA or RNA encoding and expressing a protein tyrosine phsphatase polypeptide, which catalyzes dephosphorylation of tyrosyl residue
06/19/2003US20030113293 Fusion proteins; bacteriophage capsids; cytokines; bacteriocins; antitumor agents
06/19/2003CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003CA2692325A1 Islet cells from human embryonic stem cells
06/19/2003CA2470104A1 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
06/19/2003CA2469792A1 In vitro production of dendritic cells from cd14+ monocytes especially for the preparation of suspension, monolayer and three-dimensional cell and/or tissue models, and use of these models
06/19/2003CA2469620A1 Immunisation against chlamydia trachomatis
06/19/2003CA2469494A1 Novel chimeric tnf ligands
06/19/2003CA2469491A1 Composition for viral preservation
06/19/2003CA2469483A1 Hematopoietic cells from human embryonic stem cells
06/19/2003CA2469310A1 Plasmid mediated supplementation for treating chronically ill subjects
06/19/2003CA2469161A1 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003CA2469049A1 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003CA2469027A1 Human genes and gene expression products isolated from human prostate
06/19/2003CA2467721A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/19/2003CA2461491A1 Methods of screening for antagonists of apm1/gzip
06/18/2003EP1319713A1 Complex
06/18/2003EP1319669A2 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
06/18/2003EP1319419A1 Method of administration of a gene of interest to a vascular tissue
06/18/2003EP1319082A2 Expression vectors containing hybrid ubiquitin promoters
06/18/2003EP1319075A2 The c. albicans tec1 gene (catec1) and the coded tec1p protein
06/18/2003EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319064A2 Gsk3 polypeptides
06/18/2003EP1319014A1 Antisense modulation of flip-c expression
06/18/2003EP1318841A2 Control of nk cell function and survival by modulation of ship activity
06/18/2003EP1318840A2 PHOSPHATONIN-RELATED GENE AND i METHODS OF USE THEREOF /i
06/18/2003EP1318839A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
06/18/2003EP1318838A1 Use of a nucleic acid/pei complex
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318835A1 Use of imidazoquinolinamines as adjuvants in dna vaccination
06/18/2003EP1318831A2 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism
06/18/2003EP1032428B1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/18/2003EP0936902B1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
06/18/2003EP0821739B1 An adenovirus helper-virus system
06/18/2003CN1425073A 病毒株 Strains
06/18/2003CN1425072A Gene therapy of HIV-positive patients by the expression of membrane-anchored gp41 peptides
06/18/2003CN1425066A Novel stra6 polypeptides
06/18/2003CN1425065A Method of controlling telomere length
06/18/2003CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene
06/18/2003CN1424914A Carbon dioxide enhancement of inhalation therapy
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1424401A Conditional duplicated adenovirus and its establishment and use
06/18/2003CN1424044A Gene medicine against mammitis of dairy cow
06/17/2003US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use
06/17/2003US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist
06/17/2003US6579856 Inhibition of stress activated protein kinase (SAPK) pathway and sensitization of cells to cancer therapies
06/17/2003US6579855 Adenovirus-mediated gene therapy
06/17/2003US6579850 Polypeptide, novel DNA and novel antibody
06/17/2003US6579678 Identifying evolved polynucleotides using recursive sequence recombination; recombining overlapping nucleotide sequences; screening for desired property; use in correlating different combinations of mutations with a desired result
06/17/2003US6579674 Administering antisense VA 1 (ava 1) oligodeoxynucleotides with carrier
06/17/2003US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/17/2003US6579523 Transplants for myocardial scars
06/17/2003US6579522 Replication deficient adenoviral TNF vector
06/17/2003CA2118816C Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/13/2003WO2003047602A1 Immunostimulatory oligodeoxynucleotides
06/13/2003CA2452909A1 Immunostimulatory oligodeoxynucleotides
06/12/2003WO2003048775A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048362A2 Suppression of polymeric alleles
06/12/2003WO2003048361A2 P55pik
06/12/2003WO2003048354A1 Protein-decomposing/eliminating enzyme and utilization thereof
06/12/2003WO2003048352A2 Histone h3 methyltransferase polypeptide
06/12/2003WO2003048350A1 Regulation of human lactate dehydrogenase
06/12/2003WO2003048338A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
1 ... 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 ... 870